aTyr Pharma, Inc. (ATYR) - Earnings growth in current year
aTyr Pharma, Inc. (ATYR) leverages bioinformatic AI and robotics for precise protein modeling, enabling management to focus on developing innovative treatments for pulmonary pathologies. The annual EPS change ratio visualizes this trend, where the value of 37.20 reflects this status. Patents for tRNA synthetases and high FDA compliance costs protect the business, creating a significant technological barrier.
Comprehensive metric breakdowns and analytics for aTyr Pharma, Inc. (ATYR)
- price and consensus price forecast:
- market capitalization indicators:
- book capitalization data:
- debt and liquidity details:
Total Debt to Capital aTyr Pharma, Inc.|ATYR - Long-Term Debt to Equity Ratio|Short-Term Loans to Capital Ratio aTyr|ATYR - Company Total Debt|Debts to Book Value aTyr Pharma, Inc.|ATYR - Company Long-Term Debt|Company Short-Term Loans and Borrowings aTyr Pharma|Intermediate Coverage Ratio atyrpharma.com
- earnings and market ratios statistics:
ATYR - Company Net Income|Forward Earnings aTyr Pharma, Inc.|ATYR - P/E Multiple|Future Price to Earnings Multiple aTyr Pharma, Inc.|ATYR - PEG Multiple|EV/EBITDA Multiple aTyr Pharma, Inc.|ATYR - Profit before payment of interest, taxes and amortization|Earnings per share for the trailing year aTyr Pharma|ATYR - Earnings per share for the last twelve months|Year-over-year net earnings per share growth for the last 12 months atyrpharma.com|ATYR - Earnings growth in current year|Earnings growth forecast for next year aTyr Pharma, Inc.
- sales volume and revenue information:
Summary company analysis:ATYR aTyr Pharmaceuticals
For the scientific pioneer in fibrosis therapy aTyr Pharma, Inc. (ATYR), the year-over-year percentage change in EPS serves as an indicator of financial efficiency. This metric captures the dynamics of net income per share relative to the same period last year. The calculation reflects the company's ability to generate income amid costly tRNA research. Growth in this indicator confirms the commercialization of developments and margin stability, allowing investors to assess the risk of capital freeze.
Main competitors
Net earnings per share growth this year argenx SE|Net earnings per share growth this year BNTX|Earnings growth in current year Abivax SA|Earnings per share growth in current year ADMA Bio (ADMA)|Protagonist - Earnings per share growth this year|Earnings growth in current year IMVT (immunovant.com)|Kiniksa Corp (KNSA) - Earnings per share growth rate in current year|Grifols Biemat - Earnings growth in current year|ADPT - Earnings growth in current year|CLDX: Earnings growth in current year|Aurinia Pharmaceuticals Inc (AUPH) - Earnings growth in current year|Earnings per share growth in current year biocryst.com|VERA: Earnings per share increase in current year|Earnings per share growth in current year Dianthus Therapeutics, Inc. (DNTH)|PHVS (Pharvaris) - Earnings per share increase in current year|Earnings per share growth in current year AbCellera ABCL|TRML - Net earnings per share growth this year|Precigen Inc - Earnings growth in current year|Expected net earnings per share growth this year Pharming Corp PHAR|NKTR (Nektar Therapeutics) - Net earnings per share growth this year|Net earnings per share growth this year Upstream Bio|ZBIO (Zenas Bio) - Earnings growth in current year|Earnings per share growth rate in current year Immunome Corp IMNM|Net earnings per share growth this year GOSS (Gossamer Corp)|KALV (KalVista Corp) - Earnings per share increase in current year|Earnings growth in current year SEPN (septerna.com)|Earnings growth in current year pieris.com PVLA|SVRA: Net earnings per share growth this year|Rigel Pharmaceuticals, Inc. (RIGL) - Net earnings per share growth this year|ANAB: Earnings growth in current year|Astria Corp (ATXS) - Earnings growth in current year|Earnings per share growth in current year enGene|Earnings growth in current year RAPT Therapeutics|Earnings growth in current year JBIO|ACRS: Earnings per share trend in current year|Earnings growth in current year KYTX (kyvernatx.com)|TLSA - Net earnings per share growth this year|CABA - Earnings per share growth in current year|Ventyx Biosciences (VTYX) - Net earnings per share growth this year|Theratechnologies, Inc. (THTX) - Earnings per share growth in current year|Net earnings per share growth this year Avalo Therapeutics, Inc.|ELDN (Eledon Pharmaceuticals, Inc) - Earnings growth in current year|Agenus, Inc (AGEN) - Expected net earnings per share growth this year|Earnings growth in current year CLYM|ZURA (Zura Bio Limited) - Earnings per share increase in current year|Earnings per share growth in current year Adagene ADAG|Earnings per share increase in current year IMA|STTK: Net earnings per share growth this year|Earnings per share increase in current year EQ (equilliumbio.com)|Connect Biopharma Holdings Limited (CNTB) - Earnings per share growth in current year|Immunic, Inc. (IMUX) - Earnings growth in current year|Net earnings per share growth this year ATRA|IFRX: Earnings per share increase in current year|X4 Pharmaceuticals Inc. (XFOR) - Earnings per share increase in current year|Net earnings per share growth this year Adicet ACET|Earnings growth in current year CELU (Celularity Inc)|Earnings growth in current year INmune Bio INMB|Barinthus Biotherapeutics plc - Earnings growth in current year|Kezar Life Sciences, Inc. (KZR) - Net earnings per share growth this year|SAB Biotherapeutics, Inc (SABS) - Earnings per share growth in current year|Net earnings per share growth this year Akari Therapeutics plc|Earnings per share growth in current year enlivex.com|Earnings per share growth rate in current year q32bio.com QTTB|Earnings per share growth in current year GeoVax Labs (GOVX)|EDSA (Edesa Biotech) - Earnings per share increase in current year|Earnings per share growth in current year ibioinc.com IBIO|Earnings growth in current year carismatx.com CARM|XTLB - Earnings per share growth in current year|Earnings per share increase in current year BOLT (boltbio.com)|HCW Biologics Inc (HCWB) - Earnings per share growth in current year|Net earnings per share growth this year Aptevo|Net earnings per share growth this year AIM|Earnings per share growth this year ADTX (aditxt.com)|Earnings per share growth in current year GRI Bio Inc (GRI)|XRTX (XORTX Therapeutics Inc.) - Earnings per share increase in current year|Earnings growth in current year HIND (Vyome Therapeutics)|REVB - Net earnings per share growth this year|INDP: Net earnings per share growth this year|Earnings per share increase in current year SCNI (Scinai)|CALI: Earnings growth in current year|Affimed NV - Earnings per share increase in current year|ALLK (Allakos) - Earnings growth in current year|Earnings per share growth rate in current year hookipapharma.com HOOK|Earnings growth in current year IGMS|ITOS - Earnings per share growth rate in current year|Earnings growth in current year OCEA (oceanbiomedical.com)|Net earnings per one share growth for the current year TCBP (TC Biopharm)|THRD: Net earnings per share growth this year
